13F filer · CIK 946431 ↗
Swedbank AB
You are looking at Q1 2024. See the latest, Q3 2026 →
Reported value
$70.85B
+14% on the quarter before
Positions
712
37 new · 25 sold out
Top 10
34.2%
of the value
Est. gain
+$6.54B
on stocks held all quarter
Est. return
+11.3%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Swedbank AB's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$702.5MAdded · 4.2% → 4.3%+4,096,566 shares
- Salesforce~$592.1MAdded · 0.4% → 1.2%+1,966,044 shares
- Linde Plc 2~$434.6MNew · 0.0% → 0.6%+935,997 shares
- Amazon~$361.0MAdded · 2.5% → 3.2%+2,001,301 shares
- Meta~$325.8MAdded · 1.6% → 2.3%+670,992 shares
- Eaton Corp~$267.5MNew · 0.0% → 0.4%+855,586 shares
- Autoliv (Us)~$236.0MNew · 0.0% → 0.3%+1,959,614 shares
- Unitedhealth Gro~$182.5MAdded · 1.6% → 1.6%+368,856 shares
- Microsoft~$154.0MAdded · 7.8% → 7.9%+366,019 shares
- Cooper Companies~$139.2MNew · 0.0% → 0.2%+1,372,420 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$720.4MCut · 4.1% → 5.5%−797,333 shares
- Linde Plc~$393.6MSold out · 0.6% → 0.0%−958,433 shares
- Broadcom~$379.9MCut · 4.4% → 4.0%−286,637 shares
- IntelPUT~$301.5MSold out · 0.5% → 0.0%−6,000,000 underlying
- Eaton Corp Plc~$225.5MSold out · 0.4% → 0.0%−936,552 shares
- ApplePUT~$193.4MSold out · 0.3% → 0.0%−1,000,000 underlying
- Cigna Corp~$193.4MCut · 0.5% → 0.2%−532,546 shares
- Adobe~$182.0MCut · 1.5% → 0.9%−360,592 shares
- Alphabet~$146.6MCut · 2.4% → 2.0%−971,410 shares
- Jazz Pharmaceuticals Plc~$126.7MSold out · 0.2% → 0.0%−1,030,228 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +2.8% · price +11.9% | 7.9% | $5.59B | +$577.0M | ||||||||
| NvidiaCOM · shares −16% · price +82.5% | 5.5% | $3.92B | +$1.77B | ||||||||
| AppleCOM · shares +30% · price −10.9% | 4.3% | $3.03B | −$285.3M | ||||||||
| BroadcomCOM · shares −12% · price +18.7% | 4.0% | $2.84B | +$447.5M | ||||||||
| AmazonCOM · shares +19% · price +18.7% | 3.2% | $2.24B | +$296.2M | ||||||||
| MetaCOM · shares +24% · price +37.2% | 2.3% | $1.66B | +$360.6M | ||||||||
| AlphabetCOM · shares −9.2% · price +8.0% | 2.0% | $1.44B | +$107.3M | ||||||||
| AlphabetCOM · shares −3.2% · price +8.0% | 1.9% | $1.38B | +$102.6M | ||||||||
| Unitedhealth GroCOM · shares +20% · price −6.0% | 1.6% | $1.12B | −$60.0M | ||||||||
| SynopsysCOM · shares −5.9% · price +11.0% | 1.5% | $1.05B | +$104.1M | ||||||||
| Eli LillyCOM · shares +4.1% · price +33.5% | 1.3% | $932.8M | +$224.7M | ||||||||
| Centene CorpCOM · shares −5.2% · price +5.8% | 1.3% | $914.1M | +$49.7M | ||||||||
| ServiceNowCOM · shares −0.04% · price +7.9% | 1.3% | $897.9M | +$65.8M | ||||||||
| SalesforceCOM · shares +210% · price +14.5% | 1.2% | $874.7M | +$35.7M | ||||||||
| CiscoCOM · shares −0.2% · price −1.2% | 1.2% | $840.5M | −$10.3M | ||||||||
| Accenture PlcCOM · shares −4.0% · price −1.2% | 1.2% | $820.9M | −$10.2M | ||||||||
| Berkshire HathawCOM · shares −3.7% · price +17.9% | 1.1% | $810.4M | +$123.1M | ||||||||
| Jpmorgan Chase &COM · shares +7.6% · price +17.8% | 1.1% | $800.1M | +$112.1M | ||||||||
| Applied MaterialsCOM · shares +3.7% · price +27.2% | 1.1% | $773.6M | +$159.7M | ||||||||
| Merck & Co Inc/NCOM · shares +1.4% · price +21.0% | 1.0% | $724.8M | +$124.2M | ||||||||
| Thermo Fisher ScCOM · shares +0.7% · price +9.5% | 1.00% | $705.6M | +$60.8M | ||||||||
| Danaher CorpCOM · shares −9.6% · price +7.9% | 0.95% | $676.5M | +$49.8M | ||||||||
| Mckesson CorpCOM · shares −0.01% · price +16.0% | 0.94% | $669.3M | +$92.1M | ||||||||
| MastercardCOM · shares +1.3% · price +12.9% | 0.93% | $660.7M | +$74.6M | ||||||||
| KeysightCOM · shares −1.4% · price −1.7% | 0.88% | $622.0M | −$10.8M | ||||||||
| Total · 712 positions | 100% | $70.85B | +$6.54B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 674 stocks held throughout, up $6.54B (+11.3%).
- Nvidia+$1.77B+82%
- Microsoft+$577.0M+12%
- Broadcom+$447.5M+19%
- Meta+$360.6M+37%
- Amazon+$296.2M+19%
- Unitedhealth Gro−$60.0M−6%
- Tesla−$74.9M−29%
- Solaredge Techno−$83.3M−24%
- Adobe−$113.3M−15%
- Apple−$285.3M−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 27, 2026 | $117.74B+2% | SEC ↗ |
| Q2 2026 | Jul 15, 2026 | $115.99B+22% | SEC ↗ |
| Q1 2026 | Apr 29, 2026 | $95.15B−8% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 (amended) | $103.37B+5% | SEC ↗ |
| Q3 2025 | Oct 15, 2025 | $98.65B+11% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $88.96B+9% | SEC ↗ |
| Q4 2024 | Jan 22, 2025 | $81.32B+4% | SEC ↗ |
| Q3 2024 | Oct 11, 2024 (amended) | $78.51B+5% | SEC ↗ |
| Q2 2024 | Jul 11, 2024 | $74.81B+6% | SEC ↗ |
| Q1 2024 | May 13, 2024 (amended) | $70.85B+14% | SEC ↗ |
| Q4 2023 | Dec 6, 2024 | $62.11B+8% | SEC ↗ |
| Q3 2023 | Dec 6, 2024 | $57.73B−2% | SEC ↗ |
| Q2 2023 | Dec 6, 2024 | $58.98B+16% | SEC ↗ |
| Q1 2023 | Dec 6, 2024 | $50.71B+12% | SEC ↗ |
| Q4 2022 | Dec 6, 2024 | $45.47B+8% | SEC ↗ |
| Q3 2022 | Dec 6, 2024 | $42.13B−5% | SEC ↗ |
| Q2 2022 | Dec 6, 2024 | $44.30B−18% | SEC ↗ |
| Q1 2022 | Dec 6, 2024 | $53.93B−10% | SEC ↗ |
| Q4 2021 | Dec 6, 2024 | $59.82B+12% | SEC ↗ |
| Q3 2021 | Dec 6, 2024 | $53.56B+0% | SEC ↗ |
| Q2 2021 | Dec 6, 2024 | $53.31B+11% | SEC ↗ |
| Q1 2021 | Dec 6, 2024 | $48.14B | SEC ↗ |